$217.81
$0.00 (0.00%)
End-of-day quote: 05/24/2024
NasdaqGS:BIIB
Biogen Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | NYSE | Outperform | $807.43 | $636.99 | 0.00% | 9 | $727.01B |
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr919.70 | kr696.07 | 0.00% | 14 | kr4.08T |
| JNJ | Johnson & Johnson | NYSE | Outperform | $146.97 | $174.55 | 0.00% | 3 | $353.71B |
| MRK | Merck | NYSE | Outperform | $129.49 | $130.51 | 0.00% | 11 | $327.97B |
| ABBV | AbbVie | NYSE | Outperform | $157.06 | $178.42 | 0.00% | 11 | $277.35B |
| AZN | AstraZeneca PLC | LSE | Outperform | £122.96 | £165.99 | 0.00% | 16 | £190.62B |
| NOVN | Novartis | SWX | Hold | CHF92.03 | CHF105.00 | 0.00% | 9 | CHF187.78B |
| ROG | Roche Holding | SWX | Hold | CHF229.90 | CHF307.83 | 0.00% | 9 | CHF185.94B |
| DHR | Danaher | NYSE | Outperform | $262.78 | $260.33 | 0.00% | 4 | $194.64B |
| AMGN | Amgen | NasdaqGS | Outperform | $305.84 | $303.65 | 0.00% | 8 | $164.06B |
| PFE | Pfizer | NYSE | Outperform | $28.88 | $32.87 | 0.00% | 6 | $163.65B |
| SAN | Sanofi | ENXTPA | Outperform | 89.86€ | 102.80€ | 0.00% | 9 | 112.34€B |
| VRTX | Vertex Pharmaceuticals Inc | NASDAQ | Outperform | $456.95 | $457.59 | 0.00% | 11 | $117.92B |
| MDT | Medtronic | NYSE | Outperform | $82.29 | $92.47 | 0.00% | 9 | $107.91B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $985.02 | $961.26 | 0.00% | 8 | $106.27B |
| GSK | GSK | LSE | Outperform | £17.75 | £17.30 | 0.00% | 12 | £72.36B |
| CSL | CSL | ASX | Outperform | $280.64 | $205.51 | 0.00% | 5 | $135.62B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $41.24 | $58.15 | 0.00% | 10 | $83.60B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $65.68 | $87.82 | 0.00% | 14 | $81.83B |
| MRK | Merck KGaA | XTRA | Outperform | 167.40€ | 190.06€ | 0.00% | 4 | 72.78€B |
| ZTS | Zoetis | NYSE | Outperform | $170.07 | $220.47 | 0.00% | 5 | $77.60B |
| MRNA | Moderna | NasdaqGS | Outperform | $166.61 | $135.42 | 0.00% | 1 | $63.85B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| DSFIR | DSM-Firmenich | ENXTAM | Outperform | 106.70€ | 114.60€ | 0.00% | 0 | 28.31€B |
| BAYN | Bayer | XTRA | Hold | 28.27€ | 45.15€ | 0.00% | 4 | 27.77€B |
| DIM | Sartorius Stedim Biotech | ENXTPA | Outperform | 187.65€ | 254.69€ | 0.00% | 3 | 18.26€B |
| TEVA | Teva Pharmaceutical Industries | NYSE | Outperform | $16.60 | $11.59 | 0.00% | 9 | $18.80B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $147.76 | $245.24 | 0.00% | 7 | $18.69B |
| GMAB | Genmab A/S | CPSE | Outperform | kr1.96k | kr2.71k | 0.00% | 14 | kr126.06B |
| 4503 | Astellas Pharma | TSE | Outperform | ¥1.57k | ¥2.64k | 0.00% | 0 | ¥2.81T |
| CE | Celanese | NYSE | Hold | $152.87 | $148.23 | 0.00% | 18 | $16.70B |
| SY1 | Symrise | XTRA | Outperform | 106.10€ | 106.97€ | 0.00% | 5 | 14.69€B |
| BMRN | BioMarin Pharmaceutical | NasdaqGS | Outperform | $75.52 | $111.56 | 0.00% | 5 | $14.62B |
| 4523 | Eisai | TSE | Outperform | ¥6.78k | ¥9.58k | 0.00% | 0 | ¥1.97T |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $123.46 | $158.66 | 0.00% | 6 | $12.51B |
| UTHR | United Therapeutics | NasdaqGS | Outperform | $272.88 | $284.08 | 0.00% | 3 | $11.80B |
| 500124 | Dr. Reddy's Laboratories | BSE | Hold | Rp5.88k | Rp5.67k | 0.00% | 25 | Rp977.65B |
| SOBI | Swedish Orphan Biovitrum AB (p... | OM | Outperform | kr276.20 | kr293.00 | 0.00% | 6 | kr96.39B |
| CRDA | Croda International Plc | LSE | Outperform | £46.29 | £65.12 | 0.00% | 6 | £6.81B |
| GRF | Grifols | BME | Outperform | 9.40€ | 18.48€ | 0.00% | 3 | 5.85€B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $37.28 | $55.60 | 0.00% | 3 | $5.76B |
| WCH | Wacker Chemie | XTRA | Outperform | 105.80€ | 145.36€ | 0.00% | 9 | 5.00€B |
| CLN | Clariant | SWX | Outperform | CHF15.10 | CHF16.11 | 0.00% | 6 | CHF4.67B |
| BIOCON | Biocon | NSEI | Hold | Rp314.95 | Rp270.86 | 0.00% | 14 | Rp365.06B |
| PRGO | Perrigo Co PLC | NYSE | Outperform | $27.88 | $44.75 | 0.00% | 0 | $4.19B |
| ALKS | Alkermes | NasdaqGS | Outperform | $24.02 | $33.27 | 0.00% | 3 | $4.11B |
| 4403 | NOF | TSE | Buy | ¥1.98k | ¥7.63k | 0.00% | 0 | ¥505.28B |
| TGTX | TG Therapeutics | NasdaqCM | Outperform | $16.71 | $29.44 | 0.00% | 6 | $2.38B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $31.22 | $28.13 | 0.00% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Hold | $25.51 | $23.40 | 0.00% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥3.57k | ¥8.34k | 0.00% | 0 | ¥261.33B |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $6.22 | $9.21 | 0.00% | 3 | $688.23M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $14.41 | $19.33 | 0.00% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $3.29 | $6.34 | 0.00% | 0 | $535.96M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.21 | $10.21 | 0.00% | 7 | $456.83M |
| AMRN | Amarin | NasdaqGM | Hold | $0.85 | $2.05 | 0.00% | 1 | $378.19M |
| NKTR | Nektar Therapeutics | NasdaqCM | Hold | $1.64 | $2.75 | 0.00% | 2 | $301.14M |
| CHRS | Coherus BioSciences | NasdaqGM | Outperform | $1.91 | $10.86 | 0.00% | 3 | $255.37M |
| PYC | PYC Therapeutics | ASX | Buy | $0.12 | $0.30 | 0.00% | 1 | $294.90M |
| MTNB | Matinas BioPharma Holdings | NYSEAM | Buy | $0.17 | $0.65 | 0.00% | 0 | $44.04M |
| ACST | Acasti Pharma | NasdaqCM | Buy | $2.72 | $16.34 | 0.00% | 0 | $26.98M |
| 542934 | Chandra Bhagat Pharma | BSE | - | Rp113.95 | Rp0.00 | 0.00% | 0 | Rp897.11M |
| ENZN | Enzon Pharmaceuticals | OTCPK | - | $0.09 | $16.00 | 0.00% | 0 | $8.48M |
| ACOR | Acorda Therapeutics | NasdaqGS | - | $0.70 | $200.00 | 0.00% | 1 | $0.53M |
| NPHC | Nutra Pharma | OTCPK | - | $0.00 | $0.53 | 0.00% | 0 | $0.01M |
| CDXI | Cardax | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |
